These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 22207583)

  • 1. Failure to clear intra-monocyte HIV infection linked to persistent neuropsychological testing impairment after first-line combined antiretroviral therapy.
    Shiramizu B; Ananworanich J; Chalermchai T; Siangphoe U; Troelstrup D; Shikuma C; De Grutolla V; Sithinamsuwan P; Praihirunkit P; Rattanamanee S; Valcour V;
    J Neurovirol; 2012 Feb; 18(1):69-73. PubMed ID: 22207583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment intensification with maraviroc (CCR5 antagonist) leads to declines in CD16-expressing monocytes in cART-suppressed chronic HIV-infected subjects and is associated with improvements in neurocognitive test performance: implications for HIV-associated neurocognitive disease (HAND).
    Ndhlovu LC; Umaki T; Chew GM; Chow DC; Agsalda M; Kallianpur KJ; Paul R; Zhang G; Ho E; Hanks N; Nakamoto B; Shiramizu BT; Shikuma CM
    J Neurovirol; 2014 Dec; 20(6):571-82. PubMed ID: 25227930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiretroviral monocyte efficacy score linked to cognitive impairment in HIV.
    Shikuma CM; Nakamoto B; Shiramizu B; Liang CY; DeGruttola V; Bennett K; Paul R; Kallianpur K; Chow D; Gavegnano C; Hurwitz SJ; Schinazi RF; Valcour VG
    Antivir Ther; 2012; 17(7):1233-42. PubMed ID: 23018140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of aging on neurocognitive performance in previously antiretroviral-naive HIV-infected individuals on their first suppressive regimen.
    Coban H; Robertson K; Smurzynski M; Krishnan S; Wu K; Bosch RJ; Collier AC; Ellis RJ
    AIDS; 2017 Jul; 31(11):1565-1571. PubMed ID: 28471765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV, antiretroviral therapies, and the brain.
    Liner KJ; Ro MJ; Robertson KR
    Curr HIV/AIDS Rep; 2010 May; 7(2):85-91. PubMed ID: 20425562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beneficial and Adverse Effects of cART Affect Neurocognitive Function in HIV-1 Infection: Balancing Viral Suppression against Neuronal Stress and Injury.
    Yuan NY; Kaul M
    J Neuroimmune Pharmacol; 2021 Mar; 16(1):90-112. PubMed ID: 31385157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV DNA in circulating monocytes as a mechanism to dementia and other HIV complications.
    Valcour VG; Shiramizu BT; Shikuma CM
    J Leukoc Biol; 2010 Apr; 87(4):621-6. PubMed ID: 20130221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV-associated dementia.
    Major EO; Rausch D; Marra C; Clifford D
    Science; 2000 Apr; 288(5465):440-2. PubMed ID: 10798979
    [No Abstract]   [Full Text] [Related]  

  • 9. Infrequent HIV Infection of Circulating Monocytes during Antiretroviral Therapy.
    Massanella M; Bakeman W; Sithinamsuwan P; Fletcher JLK; Chomchey N; Tipsuk S; Chalermchai T; Routy JP; Ananworanich J; Valcour VG; Chomont N
    J Virol; 2019 Dec; 94(1):. PubMed ID: 31597764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV-associated neurocognitive disorders and the impact of combination antiretroviral therapies.
    Ances BM; Clifford DB
    Curr Neurol Neurosci Rep; 2008 Nov; 8(6):455-61. PubMed ID: 18957181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CCR2 on Peripheral Blood CD14
    Veenstra M; Byrd DA; Inglese M; Buyukturkoglu K; Williams DW; Fleysher L; Li M; Gama L; León-Rivera R; Calderon TM; Clements JE; Morgello S; Berman JW
    J Neuroimmune Pharmacol; 2019 Mar; 14(1):120-133. PubMed ID: 29981000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dementia and neurocognitive disorders due to HIV-1 infection.
    Ances BM; Ellis RJ
    Semin Neurol; 2007 Feb; 27(1):86-92. PubMed ID: 17226745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Select resistance-associated mutations in blood are associated with lower CSF viral loads and better neuropsychological performance.
    Hightower GK; Letendre SL; Cherner M; Gibson SA; Ellis RJ; Wolfson TJ; Gamst AC; Ignacio CC; Heaton RK; Grant I; Richman DD; Smith DM;
    Virology; 2009 Nov; 394(2):243-8. PubMed ID: 19762060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathogenesis of HIV in the central nervous system.
    Valcour V; Sithinamsuwan P; Letendre S; Ances B
    Curr HIV/AIDS Rep; 2011 Mar; 8(1):54-61. PubMed ID: 21191673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Empiric neurocognitive performance profile discovery and interpretation in HIV infection.
    Gomez D; Power C; Gill MJ; Koenig N; Vega R; Fujiwara E
    J Neurovirol; 2019 Feb; 25(1):72-84. PubMed ID: 30519968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain structural and functional recovery following initiation of combination antiretroviral therapy.
    Becker JT; Cuesta P; Fabrizio M; Sudre G; Vergis EN; Douaihy A; Bajo R; Schubert A; Lopez OL; Parkkonen L; Maestu F; Bagic A
    J Neurovirol; 2012 Oct; 18(5):423-7. PubMed ID: 22692914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of HIV in the CNS: effects of antiretroviral therapy and the promise of non-antiretroviral therapeutics.
    Peluso MJ; Spudich S
    Curr HIV/AIDS Rep; 2014 Sep; 11(3):353-62. PubMed ID: 25063356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of age and time of disease with HIV-associated neurocognitive disorders: a Japanese nationwide multicenter study.
    Kinai E; Komatsu K; Sakamoto M; Taniguchi T; Nakao A; Igari H; Takada K; Watanabe A; Takahashi-Nakazato A; Takano M; Kikuchi Y; Oka S;
    J Neurovirol; 2017 Dec; 23(6):864-874. PubMed ID: 28971376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of CCR2 expressing non-classical monocytes are associated with cognitive impairment in antiretroviral therapy-naïve HIV-infected Thais.
    Ndhlovu LC; D'Antoni ML; Ananworanich J; Byron MM; Chalermchai T; Sithinamsuwan P; Tipsuk S; Ho E; Slike BM; Schuetz A; Zhang G; Agsalda-Garcia M; Shiramizu B; Shikuma CM; Valcour V;
    J Neuroimmunol; 2015 Nov; 288():25-33. PubMed ID: 26531691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of the immune system in HIV-associated neuroinflammation and neurocognitive implications.
    Hong S; Banks WA
    Brain Behav Immun; 2015 Mar; 45():1-12. PubMed ID: 25449672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.